New TREMFYA ® (guselkumab) Post-Hoc Analysis Reveals Early Efficacy Predicted Longer-Term Efficacy And Sustained Achievement Among A Diverse Active Psoriatic Arthritis Patient Population
SPRING HOUSE, PENNSYLVANIA, November 11, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a new post-hoc analysis of the Phase 3 DISCOVER program (DISCOVER-1 and DISCOVER-2) evaluating TREMFYA® (guselkumab) in adult patients with active psoriatic arthritis (PsA), which showed that early skin and enthesitis responsesa,b predicted longer-term clinical response,c including disease remission, at week 52.1 TREMFYA is the first fully human selective interleukin (IL)-23 inhibitor therapy approved in the U.S. for adults with moderate to severe plaque psoriasis (PsO) and adults with active PsA...
Source: Johnson and Johnson - November 11, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

'Rule out heart problems first!' Heart attack symptoms can mask as arthritis, warns doctor
The advice is a cautionary reminder that chest pain is not always the first sign of a heart attack. (Source: Daily Express - Health)
Source: Daily Express - Health - November 11, 2022 Category: Consumer Health News Source Type: news

Does Cracking Your Knuckles Give You Arthritis?
Doctors weigh in on this common warning from parents. (Source: Healthy Living - The Huffington Post)
Source: Healthy Living - The Huffington Post - November 11, 2022 Category: Consumer Health News Source Type: news

Arthritis warning: Two types of oily fish can cause 'sharp crystals' to form in the joints
The oily fish are high in purines, which cause a build-up of uric acid in the body - a precursor to crystals forming. (Source: Daily Express - Health)
Source: Daily Express - Health - November 10, 2022 Category: Consumer Health News Source Type: news

New TREMFYA ® (guselkumab) Post-Hoc Analysis Reveals Active Psoriatic Arthritis Patients With Early Efficacy Had Meaningful Long-Term Improvement in Health-Related Quality of Life
SPRING HOUSE, PENNSYLVANIA, November 10, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced a new post-hoc analysis of the Phase 3 DISCOVER-2 study that show early (week 8) clinical improvementsa of most measures (joint and skin disease, enthesitis and dactylitis) in adult patients with active psoriatic arthritis (PsA) treated with TREMFYA® (guselkumab) were associated with meaningful improvements in health-related quality of life (HRQoL) (measured by EQ-5D)b from year one (week 52) through year two (week 100).1 TREMFYA is the first fully human selective interleukin (IL)-23 inhibitor th...
Source: Johnson and Johnson - November 10, 2022 Category: Pharmaceuticals Tags: Latest News Source Type: news

New Inflammatory Arthritis Diagnoses Down Early in Pandemic
WEDNESDAY, Nov. 9, 2022 -- During the early phase of the pandemic, there was a decrease in new inflammatory arthritis diagnoses, according to a study published online Nov. 3 in The Lancet Rheumatology. Mark D. Russell, M.B., B.Chir., from King ' s... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 9, 2022 Category: Pharmaceuticals Source Type: news

ACR Introduces Guideline for Integrative Interventions in RA ACR Introduces Guideline for Integrative Interventions in RA
The range of recommended interventions highlighted the multidisciplinary nature of rheumatoid arthritis disease management.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 8, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Arthritis: Coconut water could relieve symptoms - 'anti-inflammatory' and 'pain-relieving'
Drinking coconut water could be one way to help relieve certain symptoms of arthritis, according to research. (Source: Daily Express - Health)
Source: Daily Express - Health - November 8, 2022 Category: Consumer Health News Source Type: news

An orally active, small-molecule TNF inhibitor that disrupts the homotrimerization interface improves inflammatory arthritis in mice | Science Signaling
A compound that blocks TNF signaling and improves inflammatory arthritis in mice is identified. (Source: Signal Transduction Knowledge Environment)
Source: Signal Transduction Knowledge Environment - November 8, 2022 Category: Science Source Type: news

Ted Danson says his psoriatic arthritis is 'killing him' - 'It's my hip'
Award-winning actor Ted Danson, 74, is struggling because of his arthritis. (Source: Daily Express - Health)
Source: Daily Express - Health - November 4, 2022 Category: Consumer Health News Source Type: news

Studies Reinvigorate RA Mucosal Origins Hypothesis Studies Reinvigorate RA Mucosal Origins Hypothesis
Two studies provide new evidence and new angles for research into determining the origins of rheumatoid arthritis and potential ways to prevent or treat the disease early.MDedge News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 4, 2022 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Thousands of arthritis cases 'were missed during Covid'
King's College London researchers said 'there is likely to be a substantial burden of undiagnosed patients' as they did not see a rebound in diagnoses after restrictions were lifted. (Source: the Mail online | Health)
Source: the Mail online | Health - November 3, 2022 Category: Consumer Health News Source Type: news

Prevalence of Arthritis Higher Among Caregivers
THURSDAY, Nov. 3, 2022 -- The prevalence of arthritis is higher among caregivers than noncaregivers, and caregivers with arthritis are more likely to report disabilities, according to research published in the Nov. 4 issue of the U.S. Centers for... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 3, 2022 Category: Pharmaceuticals Source Type: news

Caregivers Face Increased Arthritis Burden
(MedPage Today) -- People who spend time caring for relatives or friends were significantly more likely than noncaregivers to report having arthritis themselves, federal survey data indicated. Among adult participants in the 2017 and 2019 iterations... (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - November 3, 2022 Category: Primary Care Source Type: news

Janssen to Highlight Latest Scientific Advances in Hematologic Diseases at ASH 2022 with Clinical and Real-World Data Across Innovative Pipeline and Distinguished Portfolio
RARITAN, N.J., November 3, 2022 – The Janssen Pharmaceutical Companies of Johnson & Johnson are committed to redefining treatment outcomes in the hematology setting and today announced that abstracts from more than 50 company-sponsored studies, plus more than 20 investigator-initiated studies, will be presented at the American Society of Hematology (ASH) Annual Meeting in New Orleans from December 10-13, 2022. Janssen’s commitment to advancing an innovative portfolio of therapies for healthcare professionals and patients is evidenced through more than 70 presentations that span clinical studies and r...
Source: Johnson and Johnson - November 3, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news